materiaux

The new method of making mixed halide-perovskites results in solar cells with improved stability and performance. The new method results in better control over perovskite crystallization rates. This means the crystal structure is more ordered, in part due to researchers understanding and taking advantage of the faster crystallization of bromide relative to iodide.
The result is a material with fewer defects and less halide migration and thus less segregation of the bromide and iodide. This in turn means uniform mixing of bromide and iodide across the material, which allows the material to absorb light evenly. The end result is that solar cells made using the new method will perform better under real-world conditions.
Typical halide perovskite solution deposition uses an anti-solvent drip procedure to initiate crystallization of the halide film. The standard anti-solvent method for producing bromide-iodide mixed halide perovskite films often leads to excessive defect formation (e.g., bromide vacancies) owing to the rapid crystallization of bromide vs. iodide-perovskite phases. Simulations show that halide migration is enhanced in the presence of a large population of halide vacancies. This limits the stability of bromide-iodide mixed halide perovskites under light and heat.
In comparison to the anti-solvent approach, the gentler gas-quench method better controls crystallization, first producing a bromide-rich surface layer that then induces top-down columnar growth to form a gradient structure with less bromide in the bulk than in the surface region. The anti-solvent method does not produce such a gradient structure.
In this study, researchers from the National Renewable Energy Laboratory, the University of Toledo, and the University of Colorado Boulder demonstrated that the gas-quench method also produces fewer bromide vacancies and results in materials with a higher quality opto-electronic performance. Solar cells made using the gas-quench method retain desirable light absorption properties and provide enhanced performance in the form of a higher charge carrier mobility, higher open circuit voltage, and enhanced stability.

The defenses of the body’s immune system tend to destroy synthetic nanoparticles and frequently they are captured and removed from the body within few minutes. This, of course, is a major barrier to the use of nanotechnology in medicine.